Stryker CEO Kevin Lobo says robots now do 2 of every 3 knee replacements—and he won’t build them in China because ‘the IP is a massive worry’

Kevin Lobo told Fortune that Chinese companies are “knocking off a lot of the other robots” as Stryker bets $400 million on a soft-tissue surgical robot.
This is a brief. The reporting belongs to Fortune — read the complete story, with full context and credits, at the source.
Read the full story at Fortune ↗fortune.com
More from the Business desk
Just in
Why Salesforce’s stock is leading S&P 500 decliners amid tech jitters
Just in

There Will Be an Emergency Alert System Test on Tuesday. It Is Only a Test.
Just in
The latest tech failure: U.S. classified national security communications network
Just in
